Therefore, we propose that the impact of cAMP/PKA signaling on ERα activity explains how PAICS levels can be linked to estrogen-independent and 4-OHT–resistant proliferation of ERα+ breast cancer cells. This evidence concerns the gene ESR1 and breast carcinoma.